A stomach illness outbreak at the University of Guelph is part of a trend that has experts noticing a rise in stomach bugs causing vomiting and diarrhea.
Moderna, Inc. (NASDAQ:MRNA – Get Free Report) fell 8.9% on Wednesday after UBS Group lowered their price target on the stock from $108.00 to $96.00. UBS Group currently has a buy rating on the stock.
Norovirus, sometimes called the “winter vomiting disease” or “two-bucket disease” — because it causes both vomiting and diarrhea — is on the rise across the nation, even as seasonal flu is taking ...
Results that may be inaccessible to you are currently showing.